Leanne M Mancini, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Niles Road, Suite 1, St Joseph, MI 49085 Phone: 269-429-5000 Fax: 269-429-2598 |
Sigita Alimenti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 405 Momany Drive, St Joseph, MI 49085 Phone: 269-982-2099 Fax: 269-982-1950 |
Dr. Serge P Schillio, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Niles Road, Suite 1, St Joseph, MI 49085 Phone: 269-429-5000 Fax: 269-429-2598 |
Dr. Michael E Eggebrecht, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Niles Road, Suite 1, St Joseph, MI 49085 Phone: 269-429-5000 Fax: 269-429-2598 |
Dr. George L Heenan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Niles Road, Suite 1, St Joseph, MI 49085 Phone: 269-429-5000 Fax: 269-429-2598 |
News Archive
USGI Medical, Inc., the Incisionless Surgery company, today announced that updated multi-center results confirm durability of the company's Expandable Tissue Anchors- up to a year or more in a variety of incisionless gastrointestinal (GI) procedures, including use of a ROSE procedure (Repair of Surgery, Endolumenal) to repair dilated tissue after gastric bypass.
A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function.
An international team of researchers has created the first complete high-resolution map of how millions of neural fibers in the human cerebral cortex - the outer layer of the brain responsible for higher level thinking - connect and communicate. Their groundbreaking work identified a single network core, or hub, that may be key to the workings of both hemispheres of the brain.
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
› Verified 1 days ago